Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 23
Results: 21
Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3680, doi. 10.1002/cncr.35088
- Publication type:
- Article
Thymus removal in adults increases cancer risk and mortality.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3679, doi. 10.1002/cncr.35087
- By:
- Publication type:
- Article
Are multicancer early detection screening tests a hoped‐for breakthrough?: Although these tests have the potential to detect multiple cancer types earlier, research is underway to determine if their benefits outweigh their drawbacks.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3678, doi. 10.1002/cncr.35086
- By:
- Publication type:
- Article
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network meta‐analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3697, doi. 10.1002/cncr.35043
- By:
- Publication type:
- Article
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3805, doi. 10.1002/cncr.35038
- By:
- Publication type:
- Article
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
- By:
- Publication type:
- Article
Top advances of the year: Myeloproliferative neoplasms.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3685, doi. 10.1002/cncr.35028
- By:
- Publication type:
- Article
The reignition of the Cancer Moonshot: An opportunity missed?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3681, doi. 10.1002/cncr.35014
- By:
- Publication type:
- Article
Race‐inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3692, doi. 10.1002/cncr.35013
- By:
- Publication type:
- Article
Racial differences in serum chemokines in prostate cancer patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3783, doi. 10.1002/cncr.35012
- By:
- Publication type:
- Article
Oncology hospitalist impact on hospice utilization.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3797, doi. 10.1002/cncr.35008
- By:
- Publication type:
- Article
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3724, doi. 10.1002/cncr.35007
- By:
- Publication type:
- Article
The utility of H2 receptor antagonists in preventing infusion‐related reactions to paclitaxel chemotherapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3815, doi. 10.1002/cncr.35006
- By:
- Publication type:
- Article
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3735, doi. 10.1002/cncr.35004
- By:
- Publication type:
- Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
- By:
- Publication type:
- Article
Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow‐up care.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3820, doi. 10.1002/cncr.34984
- By:
- Publication type:
- Article
The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3790, doi. 10.1002/cncr.34981
- By:
- Publication type:
- Article
Quality of life after surgery for lower grade gliomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3761, doi. 10.1002/cncr.34980
- By:
- Publication type:
- Article
TRKing sarcomas for precision medicine: Seek, and ye shall find!
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3694, doi. 10.1002/cncr.34941
- By:
- Publication type:
- Article
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3713, doi. 10.1002/cncr.34915
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3671, doi. 10.1002/cncr.33737
- Publication type:
- Article